• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GLP-1 Guided Weight Loss Program With Physician Daily Monitoring Launched

By: Press Release Distribution Service
December 05, 2025 at 09:02 AM EST

Compass Total Wellness has launched a physician-monitored GLP-1 weight-loss program at an affordable rate with no insurance needed. The virtual service includes daily medical oversight, home medication delivery, and personalized support to help participants achieve 15-25% weight reduction within a year.

Columbus, United States, December 5, 2025 -- Compass Total Wellness has announced a new GLP-1 Guided Weight-Loss Program that provides full medical oversight for individuals seeking significant weight reduction. The virtual program offers treatment at a fixed monthly rate without insurance requirements.

More information is available at https://www.compasstotalwellness.com/product

Many weight loss attempts fail because participants lack structured support systems that address both physical progress and behavioral habits essential for long-term results.

Compass Total Wellness addresses these challenges through a program that connects participants with licensed physicians from the initial consultation onward. Physicians begin by evaluating each participant’s health status and goals to prescribe appropriate GLP-1 medications based on individual needs.

These medications work by mimicking a natural hormone that helps control blood sugar levels and regulate appetite.

Studies show that individuals using GLP-1 medications typically achieve weight loss between 15-25% after a year of treatment when combined with healthy habits. Typical qualification criteria include having a body mass index of 30 or higher, or a BMI of 27 or above with weight-related health conditions.

Participants receive their medications through home delivery, eliminating pharmacy visits and ensuring uninterrupted access. Scheduled follow-up appointments allow physicians to track progress, make necessary adjustments, and respond to emerging concerns. The medications are typically administered through weekly injections for a period of 3 to 6 months, depending on individual response and treatment goals.

Beyond weight reduction, clinical evidence shows that GLP-1 treatment combined with lifestyle interventions produces measurable improvements in cardiovascular health markers, including reductions in systolic blood pressure, total cholesterol, triglycerides, and blood glucose levels.

The program’s virtual format enables daily monitoring, giving participants immediate access to professional guidance from any location with an internet connection. Payment is processed through secure third-party systems to protect participant information during enrollment and billing.

“Beyond treatment, we focus on helping participants build healthier habits that support lasting results,” said a company representative. “Our goal is to make medically guided weight loss both accessible and effective.”

Individuals interested in medically supervised weight-loss programs can visit https://www.compasstotalwellness.com/ or call 800-735-2281 for additional information about enrollment and services.

Contact Info:
Name: Dr. Eric Kushner
Email: Send Email
Organization: Compass Total Wellness
Address: 1950 Crown Plaza Drive, Columbus, OH 43235, United States
Phone: +1-614-885-3500
Website: https://www.compasstotalwellness.com/

Source: PressCable

Release ID: 89177971

Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.

More News

View More
News headline image
Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead? ↗
Today 8:57 EST
Via MarketBeat
Tickers ULTA
News headline image
Gates Foundation Sells MSFT Stock—Should Investors Be Worried? ↗
Today 7:21 EST
Via MarketBeat
Tickers MSFT
MarketBeat Week in Review – 12/1 - 12/5 ↗
Today 7:00 EST
Via MarketBeat
Tickers AMZN COST CRWD GOOGL IBIT MDB
News headline image
Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift ↗
December 05, 2025
Via MarketBeat
Tickers RKLB
News headline image
Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish ↗
December 05, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers META

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap